BIAF

bioAffinity Technologies, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website bioaffinitytech.com
Employees(FY) 14
ISIN US09076W1099

Performance

+11.88%

1W

-20.14%

1M

+48.68%

3M

+58.04%

6M

+53.69%

YTD

+25.56%

1Y

Profile

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

Advanced Technical Analysis

Technical Analysis of BIAF 2024-05-10

Overview:

In the last 5 trading days, BIAF stock has shown a downward trend in its price, with decreasing closing prices and declining volume. The trend indicators, momentum indicators, volatility indicators, and volume indicators all point towards a bearish sentiment in the stock.

Trend Indicators:

The moving averages (MA) such as the 5-day MA...

See more ...

Recent News & Updates

2024-05-15 09:55
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024(Investorplace)
2024-05-14 21:15
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath Lung Sales and Increased Laboratory Volumes(Businesswire)
2024-05-01 20:00
bioAffinity Technologies News Update(Businesswire)
2024-04-23 20:00
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth(Businesswire)
2024-04-08 20:00
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening(Businesswire)
2024-04-01 10:53
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023(Investorplace)
2024-03-31 21:49
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results(Businesswire)
2024-03-08 00:15
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement(Prnewswire)
2024-03-07 23:45
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement(Businesswire)
2024-03-05 21:45
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement(Prnewswire)
2024-03-05 20:46
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement(Businesswire)
2024-03-04 19:00
bioAffinity Technologies Reports Accelerating Sales Growth of CyPath Lung(Businesswire)
2024-02-20 19:00
bioAffinity Technologies News Update(Businesswire)
2024-02-05 19:00
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies Medical and Scientific Advisory Board and Incorporates CyPath Lung into Medical Practice(Businesswire)
2024-01-29 19:00
bioAffinity Technologies In The News(Businesswire)
2024-01-22 19:00
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer(Businesswire)
2024-01-07 19:00
bioAffinity Technologies In the News(Businesswire)
2024-01-04 20:00
bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV(Accesswire)
2023-12-04 19:00
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors(Businesswire)
2023-11-29 19:00
CMS Posts Final Payment Determination for bioAffinity Technologies CyPath Lung Effective January 2024(Businesswire)
2023-11-27 19:00
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post(Businesswire)
2023-11-14 19:00
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening(Businesswire)
2023-11-14 03:01
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update(Businesswire)
2023-11-05 19:00
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales(Businesswire)
2023-10-09 20:00
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference(Businesswire)
2023-09-20 21:35
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference(Yahoo Finance)
2023-09-18 20:00
bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services(Yahoo Finance)
2023-09-06 20:00
bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference(Yahoo Finance)
2023-08-14 05:03
bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update(Yahoo Finance)
2023-07-11 20:00
AMA Issues CPT Code for bioAffinity Technologies CyPath® Lung Test for Early-Stage Lung Cancer(Yahoo Finance)

Page 1 of 2

previousnext